High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of infiltrating inflammatory/immune cells in HCC and can amplify inflammatory response via binding to interleukin-17 receptor...

詳細記述

保存先:
書誌詳細
主要な著者: Liao, Rui, Sun, Jian, Wu, Han, Yi, Yong, Wang, Jia-Xing, He, Hong-Wei, Cai, Xiao-Yan, Zhou, Jian, Cheng, Yun-Feng, Fan, Jia, Qiu, Shuang-Jian
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3621615/
https://ncbi.nlm.nih.gov/pubmed/23305119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料